Medical researchers have launched a Phase I clinical trial of a therapeutic melanoma vaccine designed to reprogram a patient's immune system to destroy tumors. The vaccine consists of a small disk-like, biodegradable sponge that's infused with signaling molecules and components of the patient's tumor.
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/7...
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/7...